Ultime notizie per Annovis Bio (NYSE:ANVS) Azioni

ANNOVIS BIO

Annovis Bio

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Annovis Bio Inc

Press Releases

Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering

Health Care

Annovis Bio, Inc. Announces Closing of $21 Million Public Offering

Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer's Disease

Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Annovis to Host Patients' Live Forum on February 27, 2025

News

Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment

Earnings

Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program

Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE

Management

Annovis Bio Appoints Hui Liu as Director of Biostatistics

ANVS

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics

Aligos Therapeutics

Allakos

Apimeds Pharmaceuticals US, Inc. Common Stock

Apimeds Pharmaceuticals

BioAtla

bluebird bio

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Dyadic International, Inc. - Common Stock

Dyadic International

FibroBiologics

FibroGen

Generation Bio

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

MiNK Therapeutics

Kezar Life Sciences

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

OSR Holdings

Radiopharm Theranostics Limited - American Depositary Shares

Comments

Annovis Bio

Notizie

Ultime notizie per Annovis Bio (NYSE:ANVS) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO